跳至主要内容
临床试验/NL-OMON52610
NL-OMON52610招募中不适用

SURGERY FOR ADENOCARCINOMA OF THE GASTROESOPHAGEAL JUNCTION (GEJ) TYPE II: TRANSTHORACIC ESOPHAGECTOMY VS. TRANSHIATAL EXTENDED GASTRECTOMY (CARDIA trial) - CARDIA trial

niversity of Cologne, Germany0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Principal inclusion criteria:
  • Histologically proven adenocarcinoma of the GEJ type II
  • Non distant metastatic tumor resectable by both transthoracic esophagectomy
  • and transhiatal extended gastrectomy
  • Age >=18
  • ECOG performance status < 3
  • Patients with locally advanced tumors (T3-T4 or N+) who received at least one
  • cycle of chemotherapy (FLOT) preoperatively
  • Principal exclusion criteria:
  • Adenocarcinoma of the GEJ type I and III
  • Tumor resectable only by transthoracic esophagectomy or only by transhiatal
  • extended gastrectomy
  • Positive lymph nodes only resectable by transthoracic esophagectomy (i.e. in
  • the mid-upper mediastinum) or only resectable by transhiatal extended
  • gastrectomy

排除标准

  • - Adenocarcinoma of the GEJ type I and III
  • - Tumor resectable only by transthoracic esophagectomy or only by transhiatal
  • extended gastrectomy
  • - Positive lymph nodes only resectable by transthoracic esophagectomy (i.e. in
  • the mid-upper mediastinum) or only resectable by transhiatal extended
  • gastrectomy

研究者

发起方
niversity of Cologne, Germany

相似试验